Overview

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

Status:
Completed
Trial end date:
2019-02-13
Target enrollment:
Participant gender:
Summary
This study is designed to assess the effect of PF-06865571 administration on the pharmacokinetics of metformin in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Metformin